Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bayer Aktienges ADR
(OP:
BAYRY
)
7.680
+0.010 (+0.13%)
Streaming Delayed Price
Updated: 1:52 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bayer Aktienges ADR
< Previous
1
2
3
4
5
6
Next >
Ionis Regains Rights To Thrombosis Candidate From Bayer
November 04, 2022
Via
Benzinga
Can Acquisitions and Partnerships Take Ginkgo Bioworks (DNA) Stock Higher?
October 20, 2022
It seems that Ginkgo Bioworks is announcing a new acquisition or collaboration every day this month, putting DNA stock in focus.
Via
InvestorPlace
What Is Going on With AVEO Pharmaceuticals (AVEO) Stock Today?
October 18, 2022
AVEO stock jumped on the news that LG Chem will pay $15/share for Aveo Oncology and make it the centerpiece of a new oncology division.
Via
InvestorPlace
Elon Musk Renews Twitter's Buyout Proposal, Apple Suppliers Working On Cutting China Reliance, E-Cigarette Maker Considers Bankruptcy: Top Stories Wednesday, Oct. 5
October 05, 2022
Wall Street Journal
Via
Benzinga
Roundup Weedkiller Maker Bayer Won Five Consecutive Cases, Shifting Momentum In Bayer's Favor
October 05, 2022
Bayer AG (OTC: BAYRY) won five jury verdicts in a row in trials that contended its Roundup weed killer caused non-Hodgkin lymphoma. The company battles the remaining cases targeting its Roundup...
Via
Benzinga
Bayer's Kidney Disease Drug Disappoints On Cutting Cardiovascular Death
August 29, 2022
Via
Benzinga
Bayer, Exscientia Part Ways On Artificial Intelligence Collaboration
August 18, 2022
Via
Benzinga
Top Financial Stories Wednesday, September 14: Multiple Antitrust Setbacks For Google, Bitcoin Crashes, Visa Finds New Gun Control System Ineffective And More...
September 14, 2022
Reuters
Via
Benzinga
After Investor Flak, German Healthcare Giant Bayer Starts Hunt For New CEO: Report
September 14, 2022
Via
Benzinga
BeiGene's Tislelizumab Shows Non-Inferiority In Overall Survival, Safety Vs Standard Treatment In Solid Tumors
September 12, 2022
Via
Benzinga
Deere Invests Billions In Self-Driving Tractors, Smart Crop Sprayers: Report
September 12, 2022
Via
Benzinga
FDA Approves Expanded Use For Bayer's Prostate Cancer Drug
August 08, 2022
Via
Benzinga
Read Why Did HC Wainwright Cut Price Target On Atara Biotherapeutics
May 23, 2022
Via
Benzinga
Regeneron Gains As New Data Favors Higher Dose Of Flagship Eye Disease Drug
September 08, 2022
Via
Benzinga
7 Stocks Under $15 to Buy and Hold Forever
September 01, 2022
For patient investors who are willing to absorb potential turbulence, these are the stocks under $15 to buy for the long haul.
Via
InvestorPlace
Bristol Myers Squibb, Bayer Stocks Hit The Deck On Blood Thinner Flops
August 29, 2022
The companies hoped to reduce the risk of myriad complications for at-risk patients.
Via
Investor's Business Daily
This Biotech Says Stem Cells May Be Key To Freeing 65 Million Americans From Chronic Back Pain, Painkiller Dependence
July 27, 2022
BioRestorative Therapies Inc. (NASDAQ: BRTX), a stem cell-focused biotech, says it wants to shift the paradigm of how doctors treat chronic pain in hopes of giving patients an option that’s effective,...
Via
Benzinga
Why Is Ginkgo Bioworks (DNA) Stock in the Spotlight Today?
July 25, 2022
DNA stock is down even while Ginkgo Bioworks prepares to purchase a biotech business and a large research and development site.
Via
InvestorPlace
Science Wednesday: 'Silent Spring' At 60; Preserved Baby Mammoth Found In Yukon; Filling Medical Imaging, Nursing Shortages
June 29, 2022
(This marks the first installment of Benzinga’s new weekly series Science Wednesday, which provides an overview of news and milestones within the sciences.)
Via
Benzinga
BWXT Medical, Bayer Ink Commercial Agreement For Actinium-225 Based Products
June 27, 2022
Via
Benzinga
SpringWorks Therapeutics Shares Jump On HC Wainwright Bullish Pitch
June 13, 2022
HC Wainwright points out that investors are enthusiastic about SpringWorks Therapeutics Inc (NASDAQ: SWTX) nirogacestat clinical profile for desmoid tumors after the R&D day held last week.
Via
Benzinga
7 Blue-Chip Stocks to Buy Now if You Have $250 to Spend
June 08, 2022
These seven blue-chip stocks are trading at relative bargains and they can all be added to your portfolio for less than $250.
Via
InvestorPlace
Pfizer To Quit GSK's Consumer Health JV Following Its Spin-Off
June 01, 2022
Via
Benzinga
Three Stocks To Buy In This Bear Market
May 30, 2022
There’s a silver lining to the current bear market. It’s created great buying opportunities.
Via
Talk Markets
The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara
May 20, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara
May 20, 2022
Via
Benzinga
How Heart Drugs Could Pump $10 Billion Into Merck's Coffers
May 19, 2022
As Keytruda's patent protection looms, will Merck be able to stanch the sales losses?
Via
Investor's Business Daily
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
May 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
22nd Century Group Reports Q1 Net Sales Of $9M, Up 33% YoY, Net Loss Also Grows
May 05, 2022
22nd Century Group, Inc. (NASDAQ: XXII) reported results for the first quarter ended March 31, 2022.. The company will host a live audio webcast on May 5, at 10:00 a.m. ET.
Via
Benzinga
Investment Strategy Monthly Insights, April 2022
April 22, 2022
After four decades of low inflation, developed economies are grappling with an inflation spike.
Via
Talk Markets
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.